Perfluorane and Curosurf in the Treatment of Respiratory Distress Syndrome
https://doi.org/10.15360/1813-9779-2006-3-33-35
Abstract
The article deals with the clinical investigation of the impact of perftorane and natural surfactant on the course of Adult Respiratory Distress Syndrome. The special attention was paid to the methods of endobronchial administration of these medicines, their partial efficiency and joint synergism.
About the Authors
N. V. Shapovalova
N. N. Burdenko Voronezh State Medical Academy Voronezh Regional Clinical Hospital No. 1
A. A. Lavrentyev
N. N. Burdenko Voronezh State Medical Academy Voronezh Regional Clinical Hospital No. 1
S. V. Yermolenko
N. N. Burdenko Voronezh State Medical Academy Voronezh Regional Clinical Hospital No. 1
Yu. V. Struk
N. N. Burdenko Voronezh State Medical Academy Voronezh Regional Clinical Hospital No. 1
V. PeshkovV.
N. N. Burdenko Voronezh State Medical Academy Voronezh Regional Clinical Hospital No. 1
References
1. Ashbaugh D. G., Bigelow D. B., Petty T. L., Levine B. E. Acute respiratory distress in adults. Lancet 1967; 2: 319—323.
2. Bernard G. R., Artigas A., Brigham K. L. et al. Report of the AmericanEuropean Consensus conference on acute respiratory distress syndrome: definitions, mechanisms, relevant outcomes, and clinical trial coordination. Consensus Committee. J. Crit. Care 1994; 9: 72—81.
3. Золотокрылина Е. С. Патогенез и лечение терминальных состояний, вызванных кровопотерей и травмой. В кн.: Неговский В. А. (ред.) Основы реаниматологии. Изд. 3 е. Ташкент; 1977. 221—250.
4. Luhr O. R., Antonsen К., Karlsson M. et al. Incidence and mortality after acute respiratory failure and acute respiratory distress syndrome in Sweden, Denmark, and Iceland. The ARF Study Group. Am. J. Respir. Crit. Care Med. 1999; 159: 1849—1861.
5. Demling R. H., Lalonde C., Ikegami K. Pulmonary edema: pathophysiology, methods of measurement, and clinical importance in acute respiratory failure. New Horizons 1993; 1: 371—380.
6. Bernard G. R., Artigas A., Brigham K. L. et al. The American-European consensus conference on ARDS: definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am. J. Respir. Crit. Care Med. 1994; 149: 818—824.
7. Lachmann B. The role of pulmonary surfactant in the pathogenesis and therapy of ARDS. In: Vincent J. L. (ed.). Update in intensive care and emergency medicine. Berlin Heidelberg: Springer-Verlag; 1987. 123—134.
8. Muscedere J. G., Mullen J. B., Gan K., Slutsky A. S. Tidal ventilation at low airway pressures can augment lung injury. Am. J. Respir. Crit. Care Med. 1994; 149: 1327—34.
9. Taskar V., John J., Evander E. et al. Surfactant dysfunction makes lungs ulnerable to repetitive collapse and reexpansion. Am. J. Respir. Crit. Care Med. 1997; 155: 313—320.
10. Tobin M. J. Advances in mechanical ventilation. N. Engl. J. Med. 2001; 344: 1986—1996.
11. Мороз В. В., Крылов Н. Л., Иваницкий Г. Р. и др. Применение перфторана в клинике. Анестезиол и реаниматол., 1995; 6: 12—17.
12. Хрупкин В. И., Мороз В. В., Писаренко Л. В. и др. Использование эмульсии перфторуглеродов в местном лечении ран, осложненных хирургической инфекцией. Вестн. хирургии, 1997; 4: 53—55.
13. Власенко А. В., Остапченко Д. А., Мороз В. В. и др. Способы эндобронхиального введения перфторана у больных с острым респираторным дистресс-синдромом в условиях ИВЛ. Клиническая анестезиология и реаниматология, 2004; 1 (3): 83—84.
14. Murray J. F., Matthay M. A., Luce J. M. et al. An expanded definition of the adult respiratory distress syndrome. Amer. Rev. Resp. Dis., 1988; 138 (3): 720—723.
15. Lachmann B., Eijking E. P., So K. L., Gomers D. In vivo evaluation of the inhibitory capacity of human plasma on exogenous surfactant function. Intensive Care Med. 1994; 20: 6—12.
Review
For citations:
Shapovalova N.V., Lavrentyev A.A., Yermolenko S.V., Struk Yu.V., PeshkovV. V. Perfluorane and Curosurf in the Treatment of Respiratory Distress Syndrome. General Reanimatology. 2006;2(3):33-35. (In Russ.) https://doi.org/10.15360/1813-9779-2006-3-33-35
Views:
1176
Email this article 